Cargando…
Evaluation of markers of outcome in real-world treatment of diabetic macular edema
OBJECTIVE: To evaluate short-term markers of outcome in diabetic macular edema (DME). METHODS: Prospective interventional case series included 122 eyes of 122 patients with recently diagnosed DME. Eyes were treated with a 3-monthly loading dose of ranibizumab or aflibercept and pro re nata thereafte...
Autores principales: | Campos, António, Campos, Elisa J, do Carmo, Anália, Caramelo, Francisco, Martins, João, Sousa, João P, Ambrósio, António Francisco, Silva, Rufino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198537/ https://www.ncbi.nlm.nih.gov/pubmed/30386806 http://dx.doi.org/10.1186/s40662-018-0119-9 |
Ejemplares similares
-
Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization
por: Figueira, João, et al.
Publicado: (2021) -
Thrombophilic risk factors for retinal vein occlusion
por: Vieira, Maria J., et al.
Publicado: (2019) -
Real-World Treatment Patterns and Vision Outcomes with Ranibizumab for Diabetic Macular Edema
por: Naujokaitis, Tadas, et al.
Publicado: (2021) -
Treatment of diabetic macular edema in real‐world clinical practice: The effect of aging
por: Kusuhara, Sentaro, et al.
Publicado: (2022) -
Enzymatic vitreolysis for the treatment of tractional diabetic macular edema
por: Pessoa, Bernardete, et al.
Publicado: (2019)